# An Open-label Safety, Tolerability and Exploratory Efficacy Clinical Trial of PST-611 in Geographic Atrophy

> **NCT07705568** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Eyevensys** · enrollment: 24 (estimated)

## Conditions studied

- Geographic Atrophy
- Age - Related Macular Degeneration (AMD)

## Interventions

- **BIOLOGICAL:** PST-611

## Key facts

- **NCT ID:** NCT07705568
- **Lead sponsor:** Eyevensys
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09
- **Primary completion:** 2028-06
- **Final completion:** 2028-06
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07705568

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07705568, "An Open-label Safety, Tolerability and Exploratory Efficacy Clinical Trial of PST-611 in Geographic Atrophy". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07705568. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*